.

Exhibitions & Conferences Attended by IPI with this issue:

> DIA Euro Meeting > Interphex Chicago > BIO Trinity 2013 > BIO USA > 22nd Partnership in > Pharmintech (Italy) Clinical Trials (USA) > Knowledge for Growth (ICC Ghent) > BIO Europe Spring

Volume 5 Issue 1 – February 2013 Submission deadline – 15th January 2013

Regulatory & Marketplace

> Intellectual Property & Patent Law > Pharmacovigilance / Legislation > Clinic to Commercialization > Quality Assurance / Quality Control > Child resistant packaging policies > Audience Segmentation: Personalized Marketing > eCTD Regulations > Market Access Strategies

Drug Discovery / Delivery & Therapeutics

> Improving Antibody Efficacy > Oral Drug Delivery > Stem Cells in Therapeutics > Formulation & Excipients > Fragment Based Drug Design > Pulmonary Drug Delivery > Injectable Pens & Self Injection > Biologics & Therapeutics > Smart Pill technology

Clinical & Medical Research

> Ethics Committee & Review Boards > Adaptive Clinical Trials – Personalised Medicine > Biomarkers > Clinical Patient Recruitment

> Data Management > Late Stage Research (Phase II – IV)

Clinical Trials

> Patient Recruitment & Retention > Adaptive Clinical Trials > CTS / CTMS > Pharmacokinetics (PK Studies) > Biodynamic > Named Patient Programme > Therapeutic Vaccine

Labs & Logistics

> Imaging, ECG & Core Labs > CAP Accreditation > Temperature Controlled Logistics > Analytical Labs & Testing > LIMS > Cool / Cold Chain > Margins & Operating Efficiencies

Manufacturing

> Dosage Form Production > Lean Manufacturing / Six Sigma � Solids > PAT � Capsules > Tooling

> Aseptic Processing > Pure Water / WFI > Clean Room & Contamination Control > Peptide Synthesis > Pre-formulation

Packaging

> Patient Adherence Packaging > Braille Packaging > Child resistant & Senior Friendly > Sterile Packaging / Sterile Closures > IV Bags & Delivery Systems > Moisture Barrier

IPI is Peer Reviewed. Please refer to the Editorial Guidelines section on the www.ipimediaworld.com web-site for Peer Review Protocol and Authors Guidelines.

Exhibitions & Conferences Attended by IPI with this issue:

> 49th DIA Annual Meeting > Process & Packaging Machine > Cool Chain IQPC (USA) > CDISC

International Interchange > World Stem Cell & Regenerative Medicine 2013 > BIO (BOSTON) > EPIC

Volume 5 Issue 2 – May 2013 Submission deadline – 15th April 2013

Regulatory & Marketplace

> Quality Assurance / Quality Control > lDTC Marketing > FDA Bio Research Monitoring > Programme – Protecting Human Subjects > FDA/EMA / WHO – Validation & Accreditation > Intellectual Property > Insurance & Liabilities

Drug Discovery / Delivery & Therapeutics

> Antibody Drugs for Oncology > Molecular Technology > Parenteral > Nano Technology > Custom Antibodies > Drug Implants > In vivo / In vitro > Women’s Health > Prefilled Injection Systems > Tableting (New Tablet Press generation)

Clinical & Medical Research

> Preclinical > PK / PD Studies > Imaging Technology > EDC / ePRO

> IVRS / IWRS / IXRS > Physician Liability & Ethics Review > Phase 1 / Early Stage > Cancer / Immunotherapy (Development of Monoclonal

Antibodies)

Clinical Trials

> Managing Adverse Reactions > eClinical Solutions > Patient Safety & Clinical Monitoring > CDISC > Comparator Drug Supply > ABPI New Guidelines on Phase 1 Clinical Trials

Labs & Logistics

> Imaging & Data Collection > Cool Chain & Cold Chain > IVRS / IWRS / IXRS > E – Procurement > Hazardous Cargo > Temperature Controlled Supply Chain

Manufacturing

> Pre Filled Syringes / Self Injections > Raw Materials > Ingredients & Intermediates > Sterile Fill Finish > Blow Fill Seal Technology > Lyophilisation & Freeze Drying > Containment Technology > TOC / HPLC > Softgel Technology > The Suitability of Formulations for specific

Pharmaceutical Applications Packaging

> Stability Testing & Shelf Life Management > Moisture Absorption & Moisture Barrier > Anti-Counterfeiting & Brand Protection > RFID Coding & Marking > Clinical Trials Packaging > Patient Information

The topics and subjects listed above are special fea-tures and focuses. Please refer to the media infor-mation for a list of general topics that will be featured in IPI throughout 2013. Editorial topics listed above are subject to changes, according to the movement of the industry. We will be pleased to hear from you if you have relevant topics you would like to contribute within the journal. Please email all your suggestions to – info@pharmapubs.com Current News and Press Releases can also emailed to the above email address and will be hosted at – www.ipimediaworld.com, or featured in the IPI Weekly Newsletter at our discretion.

Exhibitions & Conferences Attended by IPI with this issue:

> CPHI / ICSE / PMEC / BIOPH 2013 (Frankfurt) > BIO EUROPE – Autumn > BIO Partnering Future Europe > Partnership in Clinical Trials Europe > Scanbalt 2013

Volume 5 Issue 3 – August 2013 Submission deadline – 15th July 2013

Regulatory & Marketplace

> ICH Regulations on Monitoring > Period on New Drugs > Health Economics > ICH – GCP Guidelines > Patent Law > Insurance > Epidemiology

Drug Discovery / Delivery & Therapeutics

> Toxicity Assays > Inhalation & Nasal Drug Delivery – MDI’s & DPI’s > Diabetes > Advances in Stem Cell Technology > Imaging Technologies (Safety & Testing) > Cardiovascular / Metabolic > Biopharmaceutical Lab Services > Supporting Drug Safety

Clinical & Medical Research

> Medical Imaging > eCTD > Bio Equivalence Studies > Medical Devices > SMO/ Site Management > Pharmacovigilance & Drug Safety > Human Embryonic Stem Cells (hESCo)

Clinical Trials

> Cardiovascular Safety / QTc Prolongation > CTS/CTMS > Rescue Studies > CDISC/CDASH > Hepatic & Renal Impairment > Targeted Populations

Labs & Logistics

> Global Central Laboratories > Cardiology > Safety Testing > Time Sensitive Shipment > RFID Tracking Systems > Optical Sensing > Emerging Markets Customs

Manufacturing

> Parenteral > Semi Solids / Creams & Ointments > Neutraceuticals > Topical > IV Drug Delivery > Robotics & CAM > Filtration & Separation > Prefilled Injectable > Inhalation

Packaging

> Labelling & Bar-coding > Patient Information Leafleting > Translation & License Regulation > Electronic Notification & Intelligent Packaging

– to enhance patient compliance > Booklet Labelling > Authentication & Brand Protection

IPI is Peer Reviewed. Please refer to the Editorial Guidelines section on the www.ipimediaworld.com web-site for Peer Review Protocol and Authors Guidelines.

Exhibitions & Conferences Attended by IPI with this issue: > IQPC Cool Chain 2013 > ICSE / CPHI / BIOPH / PMEC India > Genesis > BIO Partnering (Brussels)

Volume 5 Issue 4 – November 2013 Submission deadline – 15th October 2013

Regulatory & Marketplace

> FDA / EMEA / WHO – > Helsinki Declaration – > Validation & Accreditation what it means in the current climate. > Vaccines & Adjuvant – Prevention & Cure > Cardiovascular Safety > FDA/EMA Submission Policies

Drug Discovery / Delivery & Therapeutics

> Antibody Drugs for Oncology > Parenterals > Cell Processing Tools > Fragment Based Drug Design > Custom Antibodies > Transdermal > Prefilled Injection Systems > CNS – Alzheimer’s > Cognitive Research

Clinical & Medical Research

> Managing Adverse Reactions > Phase I – IV > Preclinical > PharmacoEconomics > IMP Manufacturing & Supply > Medical Imaging

Clinical Trials

> Imaging in Oncology > Lab Validation > Temperature Controlled / Data logging > LIMS in Clinical Trials Shipment > Central, Global, Analytical Labs

Labs & Logistics

> Lab Validation > Imaging in Oncology > Temperature Controlled/Data Logging > LIMS in Clinical Trials Shipment

Manufacturing

> Leak Detection & Vision System > Quality Control & Quality Assurance > FDA & EMEA Facility Compliance > Environmental Protection & Facility Management > Solid Dosage Form production > Raman Spectroscopy > Filtration & Milling > Blending & Mixing Technologies

Packaging

> Liquids & Sachets > Blistering & De-Blistering Machines > Brand Protection > Sterile Fill Finish > Prefilled Injection Systems > RFID Coding & Marking > Clinical Trials Packaging

The topics and subjects listed above are special features and focuses. Please refer to the media information for a list of general topics that will be featured in IPI throughout 2013. Editorial topics listed above are subject to changes, according to the movement of the industry. We will be pleased to hear from you if you have relevant topics you would like to contribute within the journal. Please email all your suggestions to – info@pharmapubs.com Current News and Press Releases can also emailed to the above email address and will be hosted at – www.ipimediaworld.com, or featured in the IPI Weekly Newsletter at our discretion.